- Home
- VBNK vs TNYA Comparison
VBNK vs TNYA Comparison
Compare VBNK & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBNK
- TNYA
- Stock Information
- Founded
- VBNK 1980
- TNYA 2016
- Country
- VBNK Canada
- TNYA United States
- Employees
- VBNK N/A
- TNYA N/A
- Industry
- VBNK Commercial Banks
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- VBNK Finance
- TNYA Health Care
- Exchange
- VBNK Nasdaq
- TNYA Nasdaq
- Market Cap
- VBNK 398.2M
- TNYA 326.0M
- IPO Year
- VBNK 2021
- TNYA 2021
- Fundamental
- Price
- VBNK $11.86
- TNYA $1.43
- Analyst Decision
- VBNK Buy
- TNYA Strong Buy
- Analyst Count
- VBNK 2
- TNYA 5
- Target Price
- VBNK $15.00
- TNYA $8.60
- AVG Volume (30 Days)
- VBNK 64.2K
- TNYA 4.9M
- Earning Date
- VBNK 12-08-2025
- TNYA 11-06-2025
- Dividend Yield
- VBNK 0.60%
- TNYA N/A
- EPS Growth
- VBNK N/A
- TNYA N/A
- EPS
- VBNK 0.69
- TNYA N/A
- Revenue
- VBNK $82,297,771.00
- TNYA N/A
- Revenue This Year
- VBNK $8.39
- TNYA N/A
- Revenue Next Year
- VBNK $31.45
- TNYA N/A
- P/E Ratio
- VBNK $17.29
- TNYA N/A
- Revenue Growth
- VBNK 0.07
- TNYA N/A
- 52 Week Low
- VBNK $8.51
- TNYA $0.36
- 52 Week High
- VBNK $18.38
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- VBNK 45.20
- TNYA 39.13
- Support Level
- VBNK $11.81
- TNYA $1.65
- Resistance Level
- VBNK $12.17
- TNYA $2.02
- Average True Range (ATR)
- VBNK 0.29
- TNYA 0.17
- MACD
- VBNK -0.05
- TNYA -0.07
- Stochastic Oscillator
- VBNK 18.72
- TNYA 3.15
About VBNK VersaBank
VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.